RNA-seq analysis of 15 breast cancer cell lines indicated that there was a trend to higher expression of GLS in TNBC cell lines compared with ER+ and HER2-amplified cell lines but not of other genes in these metabolic pathways (Supplementary Fig. S11D). The gene discussed is ERBB2; the disease is breast cancer.